Systemic effects of chronic obstructive pulmonary disease

Novartis Foundation Symposium

Volumn 234, Issue , 2001, Pages 242-254

  Agustí, Alvar G N ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGENITAL MALFORMATION; HUMAN; IMMUNOLOGY; METABOLISM; NUTRITIONAL DISORDER; REVIEW; SKELETAL MUSCLE;

HUMANS; LUNG DISEASES, OBSTRUCTIVE; MUSCLE, SKELETAL; NUTRITION DISORDERS;

EID: 0035218680     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (35)

1. Agustí AGN, Villaverde JM, Togores B 1999a Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. Eur Respir J 14:523-528
2. Agustí AGN, Noguera A, Batle S et al 1999b Neutrophil function and susceptibility to chronic obstructive pulmonary disease. Eur Respir J 14:358s (abstr)
3. Agustí AGN, Sauleda J, Batle S et al 2000 Skeletal muscle apoptosis in COPD. Eur Respir J, in press
4. American Thoracic Society, European Respiratory Society 1999 Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:S1-S40
5. Baarends EM, Schols AM, Westerterp KR, Wouters EF 1997 Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD. Thorax 52:780-785
6. Baudouin SV, Bott J, Ward A, Deane C, Moxham J 1992 Short term effect of oxygen on renal haemodynamics in patients with hypoxaemic chronic obstructive airways disease. Thorax 47:550-554
7. Bernard S, Leblanc P, Whittom F et al 1998 Peripheral muscle weakness in patient with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158:629-634
8. Campbell JL, Calverley PMA, Lamb D, Flenley DC 1982 The renal glomerulus in hypoxic cor pulmonale. Thorax 37:607-611
9. Celermajer DS, Adams MR, Clarkson P et al 1996 Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 334:150-154
10. de Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM 1996 Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 153:633-637
11. Di Francia M, Barbier D, Mege JL, Orehek J 1994 Tumor necrosis factor-α levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150:1453-1455
12. Dinh-Xuan AT, Higenbottam TW, Clelland CA et al 1991 Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med 324:1539-1547
13. Howes TQ, Keilty SEJ, Maskrey VL, Deane CR, Baudouin SV, Moxham J 1996 Effect of L-arginine on renal blood flow in normal subjects and patients with hypoxic chronic obstructive pulmonary disease. Thorax 51:516-519
14. Jakobsson P, Jorfeldt L, Brundin A 1990 Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J 3:192-196
15. Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ 1997 Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 155:542-548
16. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJ 1992 Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 146:935-940
17. Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS 1996 Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 348:1115-1119
18. Li YP, Schwartz RJ, Waddell ID, Holloway BR, Reid MB 1998 Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor α. FASEB J 12:871-880
19. Maltais F, Simard AA, Simard C, Jobin J, Desgagnés P, LeBlanc P 1996 Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 153:288-293
20. Maltais F, Sullivan MJ, Leblanc P et al 1999 Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. Eur Respir J 14:850-854
21. Noguera A, Busquets X, Sauleda J, Villaverde JM, MacNee W, Agustí AGN 1998 Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158:1664-1668
22. Payen JF, Wuyam B, Levy P et al 1993 Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia. Am Rev Respir Dis 147:592-598
23. Peinado VI, Barberá JA, Ramirez J et al 1998 Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol 274:L908-L913
24. Rahman I, Morrison D, Donaldson K, MacNee W 1996 Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 154:1055-1060
25. Ries AL, Carlin BW, Casaburi R et al 1997 Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. Chest 112:1363-1396
26. Sala E, Roca J, Marrades RM et al 1999 Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:1726-1734
27. Sauleda J, García-Palmer FJ, Wiesner R et al 1998 Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:1413-1417
28. Sauleda J, Noguera A, Busquets X et al 1999 Systemic inflammation during exacerbations of chronic obstructive pulmonary disease. Lack of effect of steroid treatment. Eur Respir J 14:359s (abstr)
29. Sauleda J, García-Palmer FJ, Gonzalez G, Palou A, Agustí AGN 2000 The activity of cytochrome oxidase is increased in circulating lymphocytes of patients with chronic obstructive pulmonary disease, asthma and chronic arthritis. Am J Respir Crit Care Med 161:32-35
30. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF 1993 Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 147:1151-1156
31. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF 1996 Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 51:819-824
32. Schols AM, Slangen J, Volovics L, Wouters EF 1998 Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:1791-1797
33. Sridhar MK 1995 Why do patients with emphysema lose weight? Lancet 345:1190-1191
34. Wuyam B, Payen JF, Levy P et al 1992 Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur Respir J 5:157-162
35. Yasuda N, Gotoh K, Minatoguchi S et al 1998 An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. Respir Med 92:993-999